Organization

IDESP, Université Montpellier, INSERM, Department of Rheumatology, CHU Nîmes, Nîmes, France

1 abstract

Abstract
ADHERENCE TO MTX AT INITIATION OF FIRST TARGETED THERAPY (PREVALENCE AND ASSOCIATED FACTORS): RESULTS OF THE STRATEGE2 STUDY.
Org: IDESP, Université Montpellier, INSERM, Department of Rheumatology, CHU Nîmes, Nîmes, France, Le Mans Central Hospital, Rheumatology Department, Le Mans, France, Cabinet de Rhumatologie, NA, Marseille, France, Nordic Pharma France, Medical Department, Paris, France, Centre Hospitalier Universitaire de France, Université de Lille, Lille, France,